BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 4130665)

  • 1. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
    Aliakparova ASh
    Sov Med; 1973 Dec; 36(12):45-8. PubMed ID: 4130665
    [No Abstract]   [Full Text] [Related]  

  • 2. [Criteria for recovery from diffuse toxic goiter].
    Baranov VG; Nikolaenko NF
    Klin Med (Mosk); 1970 Apr; 48(4):50-3. PubMed ID: 4193305
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE; Burke G
    Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
    Wils JA; Kloppenborg PW
    J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.
    Chopra IJ; Chopra U; Orgiazzi J
    J Clin Endocrinol Metab; 1973 Dec; 37(6):955-67. PubMed ID: 4201831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Normalization of the functional regulation of the thyroid as a criterion of the remission of diffuse toxic goiter following antithyroid treatment].
    Khelds AO
    Probl Endokrinol (Mosk); 1986; 32(4):11-4. PubMed ID: 2429297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioisotopic indices of thyroid gland function in diffuse toxic goiter in the central Tien Shan mountains].
    Israilov AI; Kaliuzhnyĭ IT
    Zdravookhr Kirg; 1977; (2):20-3. PubMed ID: 17970
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid failure after potassium iodide treatment of diffuse toxic goiter.
    Wood LC; Maloof F
    Trans Assoc Am Physicians; 1975; 88():235-47. PubMed ID: 1243786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypothalamo-pituitary-adrenal function in hyperthyroidism and hypothyroidism].
    Ambrosi B; Beck-Peccoz P; Travaglini P; Trotto G; Faglia G
    Folia Endocrinol; 1970 Aug; 23(4):381-98. PubMed ID: 4323774
    [No Abstract]   [Full Text] [Related]  

  • 10. Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.
    Rajatanavin R; Mahatumarat P; Poochanugool L; Kumpolpunth S; Himathongkam T
    J Med Assoc Thai; 1981 Jan; 64(1):11-8. PubMed ID: 6163837
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
    Prendergast JJ; Miller JM
    Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
    Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
    Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the pituitary-thyroid axis in the drug therapy of hyperthyroidism].
    Uchiyama K
    Nihon Naibunpi Gakkai Zasshi; 1966 Nov; 42(8):884-99. PubMed ID: 4165941
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter.
    Burgos FL; Micames C; Rivera JV
    Bol Asoc Med P R; 1983 Apr; 75(4):173-5. PubMed ID: 6575791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of the hypophysis in thyroid pathology].
    Scazziga BR; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Feb; 98(5):148-56. PubMed ID: 5695037
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal liver function test in Graves' disease: a prospective study of comparison between the hyperthyroid state and the euthyroid state.
    Sarinnapakorn V; Noppavetchwich P; Sunthorntepwarakul T; Deerochanawong C; Ngongamrut S
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S11-6. PubMed ID: 21717872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxic adenoma of the thyroid gland].
    Schneck O; Eber O; Wascher H
    Wien Z Inn Med; 1966 Jul; 47(7):261-77. PubMed ID: 4187164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative evaluation of radioisotope tests to determine thyroid gland function in endemic goiters].
    Pirogov AB
    Med Radiol (Mosk); 1970 Jan; 15(1):81-3. PubMed ID: 5468445
    [No Abstract]   [Full Text] [Related]  

  • 19. [The hypothalamo-hypophyseo-thyroid system in relatives of patients with diffuse toxic goiter].
    Navarro Despaigne D; Speck Garzón P; Alávez Martín E
    Rev Clin Esp; 1985 Apr; 176(6):299-301. PubMed ID: 3839088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis of the subclinical stages of diffuse toxic goiter].
    Baranov VG; Nikolaenko NF; Stepanov GS
    Probl Endokrinol (Mosk); 1974; 20(3):35-8. PubMed ID: 4141769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.